Law

J&J Pushed Drug's Sale to Elderly After U.S. Warned of False Safety Claims Johnson & Johnson made plans to reach $302 million in geriatric sales for its antipsychotic Risperdal just months after federal regulators said the company falsely claimed the drug was safe and effective with the elderly, according to internal documents.

Billionaire Blavatnik Said to Seek as Much as 15% Stake of New Lyondell Billionaire Len Blavatnik, who controlled LyondellBasell Industries AF before it went bankrupt, is seeking a 15 percent equity stake in the reorganized company, according to a person with knowledge of the transaction.

Ex-Brocade Chief Reyes Seeks Mistrial in Second Options Backdating Case Lawyers for ex-Brocade Communications Systems Inc. Chief Executive Officer Greg Reyes asked for a mistrial in his stock options backdating case, alleging that a prosecution witness gave false testimony.

Former Deputy Comptroller Loglisci Pleads Guilty in New York Pension Probe David Loglisci, who was chief investment officer of the New York state pension fund under former comptroller Alan Hevesi, pleaded guilty over his role in what he called a “culture of corruption” at the fund.

Connecticut Says It Will Sue Moody's, S&P Over Subprime Rating Allegations Connecticut Attorney General Richard Blumenthal said he will sue Moody’s Corp. and Standard & Poor’s over allegations tied to credit ratings for subprime loans, according to an e-mailed statement today.

Buyout Funds Can't Spend $503 Billion as Venture Capital Deja Vu Threatens Buyout funds sitting on half a trillion dollars committed by investors may need more than a decade to put the money to work if mergers and acquisitions continue at the current pace.

Bloomberg Law